Embryonic Stem Cells and Pluripotent Stem Cells

Embryonic Stem Cells (ESCs) and Pluripotent Stem Cells (PSCs) are fundamental to regenerative medicine due to their remarkable ability to develop into nearly all cell types in the human body. Embryonic stem cells are derived from the inner cell mass of early-stage embryos and possess unlimited self-renewal capacity. Pluripotent stem cells, including induced pluripotent stem cells (iPSCs), can be generated by reprogramming adult somatic cells into an embryonic-like state. These cells provide powerful platforms for studying human development, disease mechanisms, and cellular differentiation. Researchers use ESCs and iPSCs to model genetic disorders, screen drug candidates, and investigate personalized therapeutic strategies. Advances in stem cell culture techniques and differentiation protocols have improved the efficiency and safety of generating specialized cell types. Induced pluripotent stem cells offer significant ethical and clinical advantages by reducing reliance on embryonic sources while enabling patient-specific therapies.

    Related Conference of Embryonic Stem Cells and Pluripotent Stem Cells

    September 24-25, 2026

    7th Annual summit on Cell Signaling and Cancer Therapy

    Paris, France

    Embryonic Stem Cells and Pluripotent Stem Cells Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in